home / stock / biib / biib articles

BIIB Articles, Biogen Inc. - From 10/10/23

Stock Information
Company Name: Biogen Inc.
Stock Symbol: BIIB
Market: NASDAQ
Website: biogen.com
Menu
BIIB BIIB Quote BIIB Short BIIB News BIIB Articles BIIB Message Board
Get BIIB Alerts

News, Short Squeeze, Breakout and More Instantly...
LuMind CEO At Odds With Neurologists Over Alzheimer's Drugs Made By Biogen, Eli Lilly | Benzinga

Hampus Hillerstrom, CEO of the Down syndrome research organization LuMind IDSC, is advocating for access to Alzheimer's drugs made by Eisa...
$1000 Invested In This Stock 20 Years Ago Would Be Worth $7,800 Today | Benzinga

Biogen (NASDAQ:BIIB) has outperformed the market over the past 20 years by 3.54% on an annualized basis producing an average annual return of 10.81...

Biogen Completes Acquisition of Reata Pharmaceuticals | Benzinga

Reata acquisition bolsters Biogen's rare disease portfolio with the addition of SKYCLARYS® (omaveloxolone), the first and only FDA appr...

Japan's Regulatory Authority Approves Biogen/Eisai's Alzheimer Treatment Leqembi | Benzinga

Eisai Co Ltd (OTC: ESALY) (OTC: ESALF) and Biogen Inc (NASDAQ: BIIB) announced that humanized anti-soluble aggregated amyloid-beta (...
California Attorney General Cracks Down On Deceptive Abortion Pill Reversal Claims | Benzinga

California Attorney General Rob Bonta has taken legal action against two anti-abortion organizations, Heartbeat International (HBI)&...

$100 Invested In Biogen 15 Years Ago Would Be Worth This Much Today | Benzinga

Biogen (NASDAQ:BIIB) has outperformed the market over the past 15 years by 3.36% on an annualized basis producing an average annual return of 12.4%...

Denali Therapeutics Breakthrough Blood-Brain Barrier Platform A Game-Changer in Neurodegenerative Diseases: Analyst | Benzinga

B Riley Securities initiated coverage on Denali Therapeutics Inc (NASDAQ: DNLI) with a Buy rating and a price target of $38.&nb...
$1000 Invested In Biogen 15 Years Ago Would Be Worth This Much Today | Benzinga

Biogen (NASDAQ:BIIB) has outperformed the market over the past 15 years by 3.91% on an annualized basis producing an average annual return of 12.94...

Previous 10 Next 10